Segment Information (Tables)

9 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Revenue by Reportable Segment

The following tables present revenue for each reportable segment and Corporate:

	Three Months Ended March 31
(in millions)	2015			2014
Pharmaceutical	$	22,605		$	18,762
Medical	2,774			2,657
Total segment revenue	25,379			21,419
Corporate (1)	(4		)	8
Total revenue	$	25,375		$	21,427

	Nine Months Ended March 31
(in millions)	2015		2014
Pharmaceutical (2)	$	66,440	$	60,018
Medical	8,540		8,168
Total segment revenue	74,980		68,186
Corporate (1)	3		4
Total revenue	$	74,983	$	68,190

(1) Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

(2) Our pharmaceutical distribution contract with Walgreen Co. expired on August 31, 2013.

Segment Profit by Reportable Segment

The following tables present segment profit by reportable segment and Corporate:

	Three Months Ended March 31
(in millions)	2015			2014
Pharmaceutical	$	567		$	452
Medical	102			111
Total segment profit	669			563
Corporate	(78		)	(55		)
Total operating earnings	$	591		$	508

	Nine Months Ended March 31
(in millions)	2015			2014
Pharmaceutical	$	1,559		$	1,368
Medical	330			348
Total segment profit	1,889			1,716
Corporate	(286		)	(218		)
Total operating earnings	$	1,603		$	1,498

Assets by Reportable Segment

The following table presents total assets for each reportable segment and Corporate at:

(in millions)	March 31, 2015		June 30, 2014
Pharmaceutical	$	16,655	$	15,361
Medical	7,183		6,768
Corporate	4,050		3,904
Total assets	$	27,888	$	26,033